Mylan Gets Approval For High Blood Pressure Patch
From Associated Press (July 19, 2010)
PITTSBURGH -- Generic drugmaker Mylan Inc. said Monday that regulators approved its generic version of Catapres-TTS high blood pressure patches.
Mylan said its patches are available for immediate shipment.
The patch delivers a drug called clonidine through the skin. The brand name version of the drug is made by German drugmaker Boehringer Ingelheim. Mylan said U.S. sales of clonidine patches totaled $313 million in the 12 months ended March 31. Par Pharmaceutical Cos. began selling a generic version last year.
In afternoon trading, Mylan shares rose 50 cents, or 2.8
percent, to $18.20.
Posted: July 2010